92 related articles for article (PubMed ID: 1446671)
41. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
42. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
[TBL] [Abstract][Full Text] [Related]
43. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
Hoeprich PD; Hugli TE
Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
[TBL] [Abstract][Full Text] [Related]
44. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
Meuer S; Ecker U; Hadding U; Bitter-Suermann D
J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
[TBL] [Abstract][Full Text] [Related]
45. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a.
Kretzschmar T; Jeromin A; Gietz C; Bautsch W; Klos A; Köhl J; Rechkemmer G; Bitter-Suermann D
Eur J Immunol; 1993 Feb; 23(2):558-61. PubMed ID: 7679650
[TBL] [Abstract][Full Text] [Related]
46. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
del Balzo UH; Levi R; Polley MJ
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
[TBL] [Abstract][Full Text] [Related]
47. Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a.
Püschel GP; Hespeling U; Oppermann M; Dieter P
Hepatology; 1993 Dec; 18(6):1516-21. PubMed ID: 8244278
[TBL] [Abstract][Full Text] [Related]
48. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
van Epps DE; Chenoweth DE
J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
[TBL] [Abstract][Full Text] [Related]
50. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
[TBL] [Abstract][Full Text] [Related]
51. Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.
Marom Z; Shelhamer J; Berger M; Frank M; Kaliner M
J Exp Med; 1985 Apr; 161(4):657-68. PubMed ID: 2580036
[TBL] [Abstract][Full Text] [Related]
52. Suppression of humoral immune responses by synthetic C3a peptides.
Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
[TBL] [Abstract][Full Text] [Related]
53. The C3a receptor antagonist SB 290157 has agonist activity.
Mathieu MC; Sawyer N; Greig GM; Hamel M; Kargman S; Ducharme Y; Lau CK; Friesen RW; O'Neill GP; Gervais FG; Therien AG
Immunol Lett; 2005 Sep; 100(2):139-45. PubMed ID: 16154494
[TBL] [Abstract][Full Text] [Related]
54. Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1999 Sep; 263(2):357-60. PubMed ID: 10491297
[TBL] [Abstract][Full Text] [Related]
55. Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig.
Watson JW; Drazen JM; Stimler-Gerard NP
Am Rev Respir Dis; 1988 Mar; 137(3):636-40. PubMed ID: 3278662
[TBL] [Abstract][Full Text] [Related]
56. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma.
Bautsch W; Hoymann HG; Zhang Q; Meier-Wiedenbach I; Raschke U; Ames RS; Sohns B; Flemme N; Meyer zu Vilsendorf A; Grove M; Klos A; Köhl J
J Immunol; 2000 Nov; 165(10):5401-5. PubMed ID: 11067890
[TBL] [Abstract][Full Text] [Related]
57. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145.
Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S
Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873
[TBL] [Abstract][Full Text] [Related]
58. Denaturation and unfolding of human anaphylatoxin C3a: an unusually low covalent stability of its native disulfide bonds.
Chang JY; Lin CC; Salamanca S; Pangburn MK; Wetsel RA
Arch Biochem Biophys; 2008 Dec; 480(2):104-10. PubMed ID: 18854167
[TBL] [Abstract][Full Text] [Related]
59. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
60. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
